Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599199 | 1.00 | HTT (0.50) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL4599420 | 1.00 | HTT (0.50) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL5833855 | 0.92 | TSHR (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL2443181 | 0.92 | TSHR (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL23038765 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL4582497 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL1095723 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL1978801 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL6021620 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL4635532 | 0.92 | DNM1 (0.48) | HTTMEN1THRBKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1343861-B1 | BRANCHED PRIMARY ALCOHOL COMPOSITIONS AND DERIVATIVES THEREOF | SHELL INT RESEARCH (NL) | 2008-04-16 | — | — | EP | disclosed |
| US-7148375-B2 | Branched primary alcohol compositions and derivatives thereof | SHELL OIL COMPANY (US) | 2006-12-12 | — | — | US | disclosed |
| US-7071364-B2 | Branched primary alcohol compositions and derivatives thereof | SHELL OIL COMPANY (US) | 2006-07-04 | — | — | US | disclosed |
| US-6909020-B2 | Branched primary alcohol compositions and derivatives thereof | SHELL OIL COMPANY (US) | 2005-06-21 | — | — | US | disclosed |
| US-6891056-B2 | Branched primary alcohol compositions and derivatives thereof | SHELL OIL COMPANY (US) | 2005-05-10 | — | — | US | disclosed |
| US-20040198628-A1 | Branched primary alcohol compositions and derivatives thereof | EDWARDS CHARLES LEE (US) | 2004-10-07 | — | — | US | disclosed |
| US-20040077894-A1 | Branched primary alcohol compositions and derivatives thereof | EDWARDS CHARLES LEE (US) | 2004-04-22 | — | — | US | disclosed |
| US-20040073055-A1 | Branched primary alcohol compositions and derivatives thereof | EDWARDS CHARLES LEE (US) | 2004-04-15 | — | — | US | disclosed |
| US-20040068133-A1 | Branched primary alcohol compositions and derivatives thereof | EDWARDS CHARLES LEE (US) | 2004-04-08 | — | — | US | disclosed |
| US-20040067867-A1 | Branched primary alcohol compositions and derivatives thereof | EDWARDS CHARLES LEE (US) | 2004-04-08 | — | — | US | disclosed |
| US-6706931-B2 | COLD WATER SOLUBLE DETERGENTS EXHIBITING HIGH CALCIUM TOLERANCE PRODUCED FROM BIODEGRADABEL BRANCHED ETHER ALCOHOLS | SHELL OIL COMPANY | 2004-03-16 | — | — | US | disclosed |
| EP-1343861-A2 | BRANCHED PRIMARY ALCOHOL COMPOSITIONS AND DERIVATIVES THEREOF | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2003-09-17 | — | — | EP | disclosed |
| US-20020151738-A1 | Branched primary alcohol compositions and derivatives thereof | SHELL OIL COMPANY | 2002-10-17 | — | — | US | disclosed |
| WO-2002050006-A2 | BRANCHED PRIMARY ALCOHOL COMPOSITIONS AND DERIVATIVES THEREOF | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068133-A1 | Branched primary alcohol compositions and derivatives thereof | ADH1A, ADH1C, ADH5 | HTT 4839/4885MEN1 3039/4885THRB 3949/4885 |
| US-20020151738-A1 | Branched primary alcohol compositions and derivatives thereof | ADH1A, ADH1C, ADH5 | HTT 4839/4885MEN1 3039/4885THRB 3949/4885 |
| US-20040077894-A1 | Branched primary alcohol compositions and derivatives thereof | ADH1A, ADH1C, ADH5 | HTT 4839/4885MEN1 3039/4885THRB 3949/4885 |
| US-20040073055-A1 | Branched primary alcohol compositions and derivatives thereof | ADH1A, ADH1C, ADH5 | HTT 4839/4885MEN1 3039/4885THRB 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.